PMC:7035340 / 9607-9850 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"300","span":{"begin":104,"end":112},"obj":"Species"},{"id":"301","span":{"begin":118,"end":127},"obj":"Species"},{"id":"304","span":{"begin":89,"end":103},"obj":"Disease"}],"attributes":[{"id":"A300","pred":"tao:has_database_id","subj":"300","obj":"Tax:9606"},{"id":"A301","pred":"tao:has_database_id","subj":"301","obj":"Tax:2697049"},{"id":"A304","pred":"tao:has_database_id","subj":"304","obj":"MESH:D016638"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"We endorse the potential benefits from low-dose corticosteroids treatment in a subset of critically ill patients with 2019-nCoV based on existing studies and clinical experience, despite there is no significant improvement in overall survival."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T36","span":{"begin":77,"end":78},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"We endorse the potential benefits from low-dose corticosteroids treatment in a subset of critically ill patients with 2019-nCoV based on existing studies and clinical experience, despite there is no significant improvement in overall survival."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T58","span":{"begin":48,"end":63},"obj":"Chemical"}],"attributes":[{"id":"A58","pred":"chebi_id","subj":"T58","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"}],"text":"We endorse the potential benefits from low-dose corticosteroids treatment in a subset of critically ill patients with 2019-nCoV based on existing studies and clinical experience, despite there is no significant improvement in overall survival."}

{"project":"LitCovid-sentences","denotations":[{"id":"T49","span":{"begin":0,"end":243},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"We endorse the potential benefits from low-dose corticosteroids treatment in a subset of critically ill patients with 2019-nCoV based on existing studies and clinical experience, despite there is no significant improvement in overall survival."}